1. Impact of Muscarinic M3 Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study

   Tran, Y-H., Schuiling-Veninga, C. C. M., Bergman, J. E. H., Groen, H. & Wilffert, B., Jun-2017, In : Cns Drugs. 31, 6, p. 483-493 11 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Drugs acting via vascular disruption and related birth defects: a systematic review

   Tran, Y. H., Wang, H., Bergman, J. E. H., Groen, H., Bakker, M. K. & Wilffert, B., Oct-2015, In : Pharmcoepidemiology and Drug Safety. 24, Suppl. 2:33, p. 33-33 1 p., P25.

   Research output: Contribution to journal › Meeting Abstract › Academic

3. Oxidative-stress-mediated teratogenesis and the role of folate

   Tran, Y. H., Bergman, J., Bakker, M., Groen, H. & Wilffert, B., 1-Feb-2016, In : Naunyn-Schmiedeberg's Archives of Pharmacology. 389, Suppliment 1, p. 14 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

4. Exposure to reactive intermediate-inducing drugs during pregnancy and the incident use of psychotropic medications among children

   Tran, Y-H., Groen, H., Bergman, J. E. H., Hak, E. & Wilffert, B., Mar-2017, In : Pharmcoepidemiology and Drug Safety. 26, 3, p. 265-273 9 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (4) »